226 related articles for article (PubMed ID: 5752748)
1. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
[No Abstract] [Full Text] [Related]
2. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
Böttiger M; Heller L; Kamensky P; Svanberg B
Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
[No Abstract] [Full Text] [Related]
3. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
Topciu V; Moldovan E; Csaky N; Băcilă E
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
[No Abstract] [Full Text] [Related]
4. Observation of the protective effect of live measles vaccines in the first year after vaccination.
Sejda J; Helcl J; Strauss J
J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
[No Abstract] [Full Text] [Related]
5. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
Boué A; Celers J
Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
[No Abstract] [Full Text] [Related]
6. [Development of measles vaccination in Austria].
Huber EG; Rannon L
Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
[No Abstract] [Full Text] [Related]
7. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
8. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
[No Abstract] [Full Text] [Related]
9. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
Sekiguchi H; Numazaki Y; Ikeda M; Yano N
Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
[No Abstract] [Full Text] [Related]
10. [Comparative evaluation of 3 measles vaccines. 3. Evaluation of the hemagglutination inhibition test for assaying measles antibodies after vaccination].
Polna I; Naruszewicz-Lesiuk D; Pilecka T
Przegl Epidemiol; 1970; 24(3):339-47. PubMed ID: 5482214
[No Abstract] [Full Text] [Related]
11. Controlled epidemiological study of live measles vaccines in Poland.
Polish Measles Vaccination Committee
Bull World Health Organ; 1971; 45(3):331-5. PubMed ID: 5316912
[TBL] [Abstract][Full Text] [Related]
12. Studies on the combined use of killed and live measles vaccines. IV. Fou years follow-up.
Ueda S; Takahashi M; Hosai H; Yamanishi K; Okuno Y
Biken J; 1969 Jun; 12(2):69-75. PubMed ID: 5346351
[No Abstract] [Full Text] [Related]
13. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
14. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
[No Abstract] [Full Text] [Related]
15. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
16. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
[No Abstract] [Full Text] [Related]
17. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
[No Abstract] [Full Text] [Related]
18. Atypical measles in children previously immunized with attenuated measles virus vaccines.
Cherry JD; Feigin RD; Lobes LA; Shackelford PG
Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
[No Abstract] [Full Text] [Related]
19. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
[No Abstract] [Full Text] [Related]
20. [Antibody status following live measles vaccine--3 years postvaccination].
Schumacher H; Welbers de Liddle IB
Dtsch Med Wochenschr; 1970 Jul; 95(31):1594-8. PubMed ID: 5431984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
